Drugs / Isocarboxazid
Isocarboxazid
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | MARPLAN | — | 1998-08-18 | fda.gov ↗ |
| Approved | US (FDA) | MARPLAN | — | 1959-07-01 | fda.gov ↗ |
Trials 1
19581959196019611962196319641965196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02323217 | Jan 2015 → Feb 2016 | Alzheimer disease | Imperial College London | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Isocarboxazid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02323217 ↗ |
| Known as | Enerzer | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201168 ↗ |
| Known as | Isocarboxazida | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201168 ↗ |
| Known as | Isocarboxazide | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201168 ↗ |
| Known as | Marplan | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201168 ↗ |
| Known as | NSC-169893 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201168 ↗ |
| Known as | RO 5-0831 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201168 ↗ |
| Modality | Small molecule | — CHEMBL1201168 ↗ |
| Route | Oral | “acute dose of isocarboxazid (up to 50 mg; p.o.)” NCT02323217 ↗ |